The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
PubMed
31359068
DOI
10.1093/ehjqcco/qcz042
PII: 5540332
Knihovny.cz E-zdroje
- Klíčová slova
- Primary percutaneous coronary intervention, Registry, Reperfusion therapy, ST-elevation myocardial infarction,
- MeSH
- akutní koronární syndrom diagnóza epidemiologie terapie MeSH
- infarkt myokardu s elevacemi ST úseků diagnóza epidemiologie terapie MeSH
- kardiologie * MeSH
- kvalita zdravotní péče * MeSH
- lidé MeSH
- management nemoci * MeSH
- registrace * MeSH
- retrospektivní studie MeSH
- společnosti lékařské * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
AIMS: The Acute Cardiac Care Association (ACCA)-European Association of Percutaneous Coronary Intervention (EAPCI) Registry on ST-elevation myocardial infarction (STEMI) of the EurObservational programme (EORP) of the European Society of Cardiology (ESC) registry aimed to determine the current state of the use of reperfusion therapy in ESC member and ESC affiliated countries and the adherence to ESC STEMI guidelines in patients with STEMI. METHODS AND RESULTS: Between 1 January 2015 and 31 March 2018, a total of 11 462 patients admitted with an initial diagnosis of STEMI according to the 2012 ESC STEMI guidelines were enrolled. Individual patient data were collected across 196 centres and 29 countries. Among the centres, there were 136 percutaneous coronary intervention centres and 91 with cardiac surgery on-site. The majority of centres (129/196) were part of a STEMI network. The main objective of this study was to describe the demographic, clinical, and angiographic characteristics of patients with STEMI. Other objectives include to assess management patterns and in particular the current use of reperfusion therapies and to evaluate how recommendations of most recent STEMI European guidelines regarding reperfusion therapies and adjunctive pharmacological and non-pharmacological treatments are adopted in clinical practice and how their application can impact on patients' outcomes. Patients will be followed for 1 year after admission. CONCLUSION: The ESC ACCA-EAPCI EORP ACS STEMI registry is an international registry of care and outcomes of patients hospitalized with STEMI. It will provide insights into the contemporary patient profile, management patterns, and 1-year outcome of patients with STEMI.
ANMCO Research Center Florence Italy
Cardiology Department Georges Pompidou European Hospital Paris France
EURObservational Research Programme ESC Sophia Antipolis France
Institute of Cardiovascular Sciences Birmingham University Birmingham UK
Internal Cardiology Department University Hospital Brno Czech Republic
Citace poskytuje Crossref.org
